Zurich Insurance Group (ZURN) H1 2020 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2020 earnings summary
17 Nov, 2026Executive summary
H1 2020 business operating profit (BOP) was $1.702bn, down 40% YoY; underlying performance was broadly in line with 2019, with COVID-19 and financial-market effects driving much of the decline.
Net income attributable to shareholders was $1.181bn, down 42% YoY; the Z-ECM ratio was estimated at 102% at June 30, within target.
Commercial insurance grew premiums and improved pricing and retention; customer support and accelerated digital services were key operational priorities.
Financial highlights
IFRS revenue was $22.527bn vs. $39.198bn; net income before tax was $1.646bn vs. $3.132bn for H1 2019.
Basic EPS was $7.98 vs. $13.81; diluted EPS was $7.90 vs. $13.67.
COVID-19-related losses recorded in H1 totaled $686m; P&C accounted for $484m and Life for $123m.
Net investment result on Group investments was $2.762bn, down 22% YoY; total investment return was 2.0% vs. 6.0%.
Outlook and guidance
Expected 2020 P&C COVID-19 claims remained $750m, fully recorded in H1; estimates remain subject to uncertainty as the event continues.
Remained committed to the three-year plan presented in November 2019, citing confidence in the strategy and ability to adapt to changing conditions.
Life APE sales began recovering as lockdowns eased, with sharp late-period recovery through key banking partners including Banco Santander.
Latest events from Zurich Insurance Group
- Beazley scales Specialty as targets, synergies and AI productivity advance.ZURN
Investor Day 2026 - Higher earnings and BOP, despite a sharp swing in unit-linked investment results.ZURN
H2 2018 - P&C underwriting gains lifted H1 BOP 16%, with combined ratio improving to 95.1%.ZURN
H1 2019 - BOP rose 16%, all three-year targets were exceeded, and a CHF 20 dividend was proposed.ZURN
H2 2019 - BOP rose 60%, while P&C’s 93.9% combined ratio marked a 20-year-plus low.ZURN
H1 2021 - COVID-19 and catastrophe losses cut BOP 20%, while commercial pricing strengthened.ZURN
H2 2020 - Record 2021 profits, stronger underwriting and 212% SST support the 2022 outlook.ZURN
H2 2021 - Higher BOP was offset by investment-market losses and an $8.8bn IFRS 17 opening-equity reduction.ZURN
H2 2022 - Record BOP and 23.1% BOPAT ROE supported higher shareholder returns.ZURN
H2 2023